~~<i id='A4B3E8B97F'><strike id='A4B3E8B97F'><tt id='A4B3E8B97F'><pre id='A4B3E8B97F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

explore

author：knowledge 2025-09-27 20:59:06 - browse：3123

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： In shift, Texas to cover initial consult for Afghan baby's gene therapy

knowledge

entertainment

leisure time

knowledge

focus

explore

ThePashaichildren(fromleft):Abubakar,Mohammad,andSufyan.Illustration:STAT;PhotoCourtesyOnasweltering

WSS

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

STAT Virtual Event: JPM Recap, Live!

Treatments for cramps don't cut it. Why aren't there better options?

Ascension's ugly legal battle over care for poor patients in Texas

A preacher's new calling: Diversifying neuroscience research

Health AI: on the border between health care and tech

entertainment

explore

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Illinois Supreme Court finds assault weapons ban constitutional

Bright Health sells Medicare Advantage business to Molina

At JPM 2024, hospital systems pitch financial strength to investors

How to save PrEP access — and even expand it

Senators push IRS to launch nonprofit hospital probe

Trump demands the U.S. pay no more for drugs than other countries … again

Study suggests new cause of Down syndrome: cells linked to aging

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Study suggests new cause of Down syndrome: cells linked to aging

entertainment

Boston Scientific acquires urology company Axonics for $3.7 billion

Indictment alleges Trump's ex

Illinois Supreme Court finds assault weapons ban constitutional

Health AI: on the border between health care and tech

Idaho college killings prosecutors challenge defense's grand jury claims

Profiling embryos to choose those with higher IQs is almost a reality

leisure time

knowledge

focus

explore